[Table_Main] 证券研究报告 | 公司点评 华熙生物(688363.SH) 2024年05月05日 华熙生物：24Q1 利润拐点明 买入（维持） 所属行业：美容护理/医疗美容 显，降本增效期待 618 表现 当前价格(元)：61.50 单击或点击此处输入文字。 证券分析师 投资要点 易丁依 资格编号：S0120523070004  华熙生物24Q1扣非+53%，增长拐点明显。1）2023年：实现营收60.76亿/yoy- 4.45%，归母净利润 5.93 亿/yoy-38.97%，扣非归母净利润 4.9亿/yoy-42.44%。 邮箱：yidy＠tebon.com.cn 23全年盈利能力下滑，毛利率73.32%/-3.67pct，销售净利率9.59%/-5.53pct；费 用端基本稳定，销售费用率 47%/-1.0pct，管理费用率 8%/+2.0pct，研发费用率 7%/+1.0pct；2）23Q4：实现营收18.54亿/yoy-9.04%，归母净利润0.78亿/yoy- 市场表现 73.37%，扣非归母净利润0.58亿/yoy-77.07%。23Q4净利下跌，毛利率73.88%/- 华熙生物 ...

Investment Rating - The report maintains a "Buy" rating for Yongxin Optics (603297 SH) [16] Core Views - Yongxin Optics is expected to achieve revenue of 1 149/1 515/2 000 billion yuan in 2024-2026 with net profit of 307/413/549 million yuan [9] - The company's PE ratio is forecasted at 27/20/15 times for 2024-2026 based on April 30 market capitalization [9] - Key growth drivers include optical microscope business benefiting from equipment replacement laser radar and medical optics [3] Business Performance Optical Microscope - NEXCOPE series revenue grew from 4 million yuan in 2018 to 140 million yuan with over 100% CAGR [3] - 2023 revenue reached 414 million yuan up 15 76% YoY though gross margin decreased by 0 9pct to 39 29% [8] - Potential growth from China's equipment replacement policy with positive customer feedback [3] Laser Radar - 2023 revenue exceeded 90 million yuan up over 50% YoY entering mass production phase [3] - Secured new projects from Hesai and Tudatong in Q1 2024 expected to drive further growth [3] Medical Optics - 2023 revenue reached 63 million yuan exceeding equity incentive targets [3] - Established deep cooperation with domestic and international medical companies achieving batch shipments [3] Barcode Scanning - Quarterly growth since Q3 2023 expected to accelerate recovery in 2024 [3] - Secured module orders from Zebra and Honeywell with batch shipments starting H2 2024 [3] Financial Performance - 2023 revenue reached 854 million yuan up 3 02% YoY though net profit declined 15 64% to 235 million yuan [18] - Q1 2024 revenue grew 14 74% YoY to 216 million yuan with net profit of 46 million yuan [18] - Gross margin improved to 37 71% in Q1 2024 up 2 2pct QoQ though down 0 98pct YoY [8] - R&D investment reached 92 million yuan in 2023 up 15 58% YoY [19] Future Outlook - Expected revenue growth of 34 6%/31 8%/32 0% for 2024-2026 [11] - Forecasted net profit growth of 30 3%/34 8%/32 8% for 2024-2026 [11] - Gross margin projected to improve to 39 8%/40 7%/41 0% in 2024-2026 [11] - ROE expected to increase from 13 0% in 2023 to 17 8% in 2026 [11]

Investment Rating - The report maintains a "Buy" rating for Wanxin Media (601801.SH) [1] Core Views - The company achieved stable profit growth in 2023, with a significant increase in the dividend payout ratio, proposing a cash dividend of RMB 3.05 per 10 shares, totaling RMB 5.97 billion, which is approximately 68.90% of the net profit attributable to shareholders [4][12] - The "AI + Education" initiative is expected to gradually establish a commercial model, with various projects such as smart classrooms and reading systems being developed [5][12] - The traditional business, including general books and teaching materials, showed steady growth, with general book revenue increasing by 23.4% year-on-year in Q1 2024 [11] Financial Performance Summary - In 2023, the company reported total revenue of RMB 112.44 billion (YoY -3.79%), with a net profit of RMB 9.36 billion (YoY +32.21%) and a non-net profit of RMB 7.54 billion (YoY +9.66%) [4] - For Q1 2024, revenue was approximately RMB 29.29 billion (YoY -5.44%), with a net profit of about RMB 2.93 billion (YoY -13.28%) and a non-net profit of RMB 3.15 billion (YoY +17.13%) [4] - The company expects revenue for 2024-2026 to be RMB 116.76 billion, RMB 120.36 billion, and RMB 125.16 billion, respectively, with net profits projected at RMB 8.56 billion, RMB 10.14 billion, and RMB 11.92 billion [12] Business Development Summary - The company completed 54 smart classroom projects and organized over 100 training sessions for smart schools [5] - The traditional business is focusing on reducing low-margin operations while expanding high-margin educational services [11] - The company has developed a reading evaluation system and enhanced teacher training programs, serving over 150,000 teachers [5]

Investment Rating - The report maintains a "Buy" rating for the company [3] Core Views - The company achieved a revenue of 4.697 billion yuan in 2023, a decrease of 20.97% year-on-year, with a net profit of 48 million yuan, down 89.01% [5] - In Q1 2024, the company reported a revenue of 1.289 billion yuan, representing a year-on-year increase of 51.13%, while net profit reached 30 million yuan, up 123.35% year-on-year [5] - The company is transitioning to a Fab-lite model, with the new factory in Lingang expected to enhance production capabilities and competitiveness in high-end image sensors [6] Financial Performance Summary - Revenue for 2023 was 4.697 billion yuan, with a net profit of 48 million yuan [7] - Projected revenues for 2024, 2025, and 2026 are 6.426 billion yuan, 8.095 billion yuan, and 9.274 billion yuan respectively [10] - The company expects net profits to rise significantly to 268 million yuan in 2024, 561 million yuan in 2025, and 655 million yuan in 2026 [9][10] Product and Market Development - The company successfully launched high-pixel single-chip products, with significant contributions from 32M and 50M products in Q1 2024 [5] - The company’s mobile CIS revenue for 2023 was 2.242 billion yuan, down 43.60%, while non-mobile CIS revenue increased by 13.43% to 1.210 billion yuan [5] - The company is expanding its product offerings in the display driver segment, with new orders for LCD TDDI products and plans for AMOLED driver ICs [6] Future Outlook - The company is expected to achieve revenues of 6.426 billion yuan in 2024, with a projected net profit of 268 million yuan, reflecting a significant recovery from previous years [8][10] - The report anticipates a strong growth trajectory for the company, with expected net profit growth rates of 455.1% in 2024 and 109.5% in 2025 [8]

[Table_Main] 证券研究报告 | 公司点评 百润股份(002568.SZ) 2024年05月04日 买入（维持） 百润股份（002568.SZ）：营收稳固增 所属行业：食品饮料/非白酒 长，费用投放短期影响盈利 当前价格(元)：20.40 证券分析师 投资要点 熊鹏 资格编号：S0120522120002 事件：公司发布2023年年报和2024年一季报。2023年公司实现营业收入32.64  邮箱：xiongpeng＠tebon.com.cn 亿元，同比+25.85%；实现归母净利润8.09亿元，同比+55.28%；实现扣非归母 研究助理 净利润7.79亿元，同比+60.08%；其中2023Q4实现营业收入8.07亿元，同比- 14.90%；实现归母净利润1.44亿元，同比-33.37%；实现扣非归母净利润1.29亿 尤诗超 元，同比-36.87%。2024Q1公司实现营业收入8.02亿元，同比+5.51%；实现归 邮箱：yousc3＠tebon.com.cn 母净利润1.69亿元，同比-9.80%；实现扣非归母净利润1.61亿元，同比-13.79%。 市场表现 各品类稳固增长，精细化渠道运营效果 ...

Investment Rating - The report maintains a "Buy" rating for the company, indicating a strong performance relative to the market [10][8]. Core Insights - The company achieved a significant milestone in 2023 with total revenue exceeding 10 billion yuan, with a year-on-year growth of 16.2%. However, the net profit decreased by 35.8% to 235 million yuan [25][3]. - In Q1 2024, the company reported a revenue increase of 10.4% year-on-year, with net profit rising by 28.2% to 130 million yuan, indicating a recovery in profitability [18][25]. - The company has seen a notable improvement in its sales channels, particularly in the North China and e-commerce sectors, which experienced growth rates of 21.9% and 182.8% respectively in 2023 [3]. Financial Summary - The company’s total revenue for 2023 was 10,121 million yuan, with projections for 2024, 2025, and 2026 at 11,330 million yuan, 12,904 million yuan, and 14,261 million yuan respectively [4][10]. - The gross margin for 2023 was 10.7%, with expectations of improvement to 11.3% in 2024 [4][10]. - The net profit margin for 2023 was 2.3%, with forecasts of 2.5% for 2024 and 3.0% for 2026 [4][10]. - The company’s total assets were reported at 7,409.34 million yuan, with a total market capitalization of approximately 7,410.68 million yuan [4][3]. Operational Highlights - The company opened 201 new stores in 2023, enhancing its store image and quality [3]. - The sales expense ratio decreased by 0.50 percentage points, while the management expense ratio saw a slight increase of 0.01 percentage points [3].

Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Views - The company is expected to see a significant profit turning point in Q1 2024, with a notable increase in net profit and a clear growth trajectory [4] - The company's functional skincare business is gradually improving, with a clear product positioning and a strengthening multi-brand matrix [5][7] - The medical aesthetics business is entering a harvest period, showing substantial revenue growth [5] - The raw materials business has also seen significant revenue growth, with an ongoing optimization of product structure [6] Financial Performance Summary - In 2023, the company achieved revenue of 6,076 million yuan, a year-on-year decrease of 4.45%, and a net profit of 593 million yuan, down 38.97% year-on-year [4][9] - The gross margin for 2023 was 73.32%, a decrease of 3.67 percentage points, while the net profit margin was 9.59%, down 5.53 percentage points [4] - For Q1 2024, the company reported revenue of 1,361 million yuan, a year-on-year increase of 4.24%, and a net profit of 243 million yuan, up 21.39% year-on-year [4] - The company anticipates revenue growth to reach 65.60 billion yuan in 2024, with net profit projected at 8.65 billion yuan, reflecting a year-on-year growth of 46.0% [7] Business Segment Insights - The functional skincare segment faced challenges in 2023, with revenue declining to 3,757 million yuan, down 18.45% year-on-year, but strategic adjustments are expected to lead to a revenue turnaround [5] - The medical terminal business achieved revenue of 1,090 million yuan in 2023, a year-on-year increase of 58.95%, with core products showing exceptional growth [5] - The raw materials segment generated revenue of 1,129 million yuan, up 15.22% year-on-year, with a focus on high-margin pharmaceutical-grade hyaluronic acid [6]

[Table_Main] 证券研究报告 | 公司点评 润本股份(603193.SH) 2024 年 05 月 05 日 所属行业：美容护理/个护用品 当前价格(元)：18.63 市场表现 -34% -23% -11% 0% 11% 润本股份 沪深300 -46% 相关研究 润本股份：23&24Q1 利润率维持高 投资要点 润本股份 23&24Q1 增长加速，盈利能力上行。1）2023 年：实现营收 10.33 亿 /+20.66%，归母净利润 2.26 亿/+41.23%，扣非归母净利 2.19 亿/+41.64%，业绩 落在此前业绩预告中值；2）23Q4：营收 2.09 亿/+19.72%，归母净利润 0.45 亿 /+58.54%，扣非归母净利 0.42 亿；3）24Q1：营收 1.67 亿/+10.02%，归母净利 润 0.35 亿/+67.93%，扣非归母净利 0.31 亿/+45.36%，预计 Q1 受到天气影响驱 蚊需求，毛利率达 55.69%/+2.85pcts，我们预计得益于高毛利产品占比提升；费 用控制稳定，销售/管理/研发费率分别为 30.15%/+1.2pct、4.32%/-0.3pct ...

Investment Rating - The investment rating for the company is "Accumulate (Maintain)" [2] Core Views - The company reported a revenue of 1.47 billion in 2023, representing a year-on-year growth of 23.9%, and a net profit attributable to shareholders of -0.02 billion, indicating a reduction in losses [9] - The company experienced significant growth in its liquor business in 2023, with revenue from liquor and biopharmaceuticals changing by +43.5% and -13.6% respectively [10] - The company plans to divest its biopharmaceutical subsidiary to focus on its core liquor business, which is expected to drive further growth [11] - The company has shown strong reform momentum, with adjusted revenue forecasts for 2024-2026 indicating growth rates of 9.0%, 26.4%, and 31.7% respectively [11] Financial Performance Summary - In 2023, the company achieved a revenue of 1,469 million, with a projected revenue of 1,601 million for 2024, reflecting a growth rate of 9.0% [19] - The net profit is expected to turn positive in 2024, with estimates of 66 million, and further growth to 278 million and 598 million in 2025 and 2026 respectively [19] - The gross margin improved to 40.3% in 2023, with expectations to rise to 45.2% in 2024 and 67.0% by 2026 [19] - The company’s return on equity is projected to improve from -0.9% in 2023 to 19.5% by 2026 [19]

Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Views - The company is expected to improve its profitability in 2024, with projected revenues of 108.6 billion yuan, 119.2 billion yuan, and 130.1 billion yuan for 2024, 2025, and 2026 respectively, reflecting year-on-year growth rates of 2.5%, 9.8%, and 9.1% [14] - The company reported a significant improvement in net profit, with a forecasted net profit of 6.3 billion yuan, 8.0 billion yuan, and 9.7 billion yuan for the same years, indicating year-on-year growth rates of 311.8%, 27.8%, and 20.9% [14] Summary by Sections Financial Performance - In 2023, the company achieved a revenue of 10,593 million yuan, a decrease of 9.3% year-on-year, and a net profit of -296 million yuan, compared to -673 million yuan in the previous year [12][16] - The first quarter of 2024 showed a revenue of 40.6 billion yuan, a slight decline of 0.75% year-on-year, but a net profit of 4.5 billion yuan, representing a growth of 37.4% [12] Business Segments - The company's revenue from liquor, pork, and real estate segments in 2023 was 68.2 billion yuan, 26.0 billion yuan, and 10.1 billion yuan respectively, with year-on-year changes of -15.9%, -4.6%, and +49.5% [3] - The liquor segment's gross margin improved by 6.0 percentage points, with high-end liquor contributing positively to this increase [13] Market Position - The company has maintained a stable dealer network, adding 5 dealers in Beijing and 20 in other regions [3] - The overall sales volume of liquor decreased by 26.0% in 2023, but the average price per ton increased by 13.8% [3] Future Outlook - The company is focusing on enhancing its core products and improving profitability through strategic pricing and marketing initiatives [3][4] - The financial forecasts indicate a recovery in profitability and revenue growth in the coming years, driven by operational improvements and market strategies [14]